OPTIBIOTIX HLTH PLC LS-02
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential… Read more
Market Cap & Net Worth: OPTIBIOTIX HLTH PLC LS-02 (OB3)
OPTIBIOTIX HLTH PLC LS-02 (F:OB3) has a market capitalization of $7.53 Million (€7.33 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #30158 globally and #3334 in its home market, demonstrating a 11.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OPTIBIOTIX HLTH PLC LS-02's stock price €0.07 by its total outstanding shares 103300304 (103.30 Million).
OPTIBIOTIX HLTH PLC LS-02 Market Cap History: 2018 to 2026
OPTIBIOTIX HLTH PLC LS-02's market capitalization history from 2018 to 2026. Data shows change from $104.16 Million to $7.53 Million (-27.98% CAGR).
OPTIBIOTIX HLTH PLC LS-02 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OPTIBIOTIX HLTH PLC LS-02's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of OB3 by Market Capitalization
Companies near OPTIBIOTIX HLTH PLC LS-02 in the global market cap rankings as of March 19, 2026.
Key companies related to OPTIBIOTIX HLTH PLC LS-02 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
OPTIBIOTIX HLTH PLC LS-02 Historical Marketcap From 2018 to 2026
Between 2018 and today, OPTIBIOTIX HLTH PLC LS-02's market cap moved from $104.16 Million to $ 7.53 Million, with a yearly change of -27.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €7.53 Million | -5.33% |
| 2025 | €7.95 Million | -62.50% |
| 2024 | €21.21 Million | -31.97% |
| 2023 | €31.17 Million | +100.00% |
| 2022 | €15.59 Million | -70.60% |
| 2021 | €53.02 Million | -11.66% |
| 2020 | €60.02 Million | -24.53% |
| 2019 | €79.53 Million | -23.65% |
| 2018 | €104.16 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of OPTIBIOTIX HLTH PLC LS-02 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.53 Million USD |
| MoneyControl | $7.53 Million USD |
| MarketWatch | $7.53 Million USD |
| marketcap.company | $7.53 Million USD |
| Reuters | $7.53 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.